BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 7358978)

  • 1. Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides.
    Anwar AR; McKean JR; Smithers SR; Kay AB
    J Immunol; 1980 Mar; 124(3):1122-9. PubMed ID: 7358978
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of neutrophil- and eosinophil-mediated complement-dependent killing of schistosomula of Schistosoma mansoni in vitro by leukotriene B4.
    Moqbel R; Sass-Kuhn SP; Goetzl EJ; Kay AB
    Clin Exp Immunol; 1983 Jun; 52(3):519-27. PubMed ID: 6307558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. II. In vitro killing of TNP-schistosomula by human eosinophils and neutrophils.
    Moser G; Sher A
    J Immunol; 1981 Mar; 126(3):1025-9. PubMed ID: 7462624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil-mediated killing of schistosomula of Schistosoma mansoni in vitro: synergistic effect of antibody and complement.
    McLaren DJ; Ramalho-Pinto FJ
    J Immunol; 1979 Oct; 123(4):1431-8. PubMed ID: 479590
    [No Abstract]   [Full Text] [Related]  

  • 5. Rat mast cell-eosinophil interaction in antibody-dependent eosinophil cytotoxicity to Schistosoma mansoni schistosomula.
    Capron M; Rousseaux J; Mazingue C; Bazin H; Capron A
    J Immunol; 1978 Dec; 121(6):2518-25. PubMed ID: 722083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for IgE-dependent cytotoxicity by rat eosinophils.
    Capron M; Bazin H; Joseph M; Capron A
    J Immunol; 1981 May; 126(5):1764-8. PubMed ID: 7217664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils.
    Anwar AR; Smithers SR; Kay AB
    J Immunol; 1979 Feb; 122(2):628-37. PubMed ID: 762435
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni by reversed type (IgE-mediated) anaphylaxis, in vitro.
    Moqbel R; MacDonald AJ; Kay AB
    Clin Exp Immunol; 1985 Mar; 59(3):577-86. PubMed ID: 3987093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
    Beswick PH; Kay AB
    Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro killing of S. mansoni schistosomula by eosinophils from infected rats: role of cytophilic antibodies.
    Capron M; Torpier G; Capron A
    J Immunol; 1979 Nov; 123(5):2220-30. PubMed ID: 489980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clq enhancement of IgG-dependent eosinophil-mediated killing of schistosomula in vitro.
    Hamada A; Greene BM
    J Immunol; 1987 Feb; 138(4):1240-5. PubMed ID: 3492545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity ot Schistosoma mansoni: antibody-dependent eosinophil-mediated damage to schistosomula.
    David JR; Butterworth AE
    Fed Proc; 1977 Jul; 36(8):2176-80. PubMed ID: 872950
    [No Abstract]   [Full Text] [Related]  

  • 13. A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni.
    Vadas MA; David JR; Butterworth A; Pisani NT; Siongok TA
    J Immunol; 1979 Apr; 122(4):1228-36. PubMed ID: 448088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of age on the susceptibility of schistosomula of Schistosoma mansoni to damage by human eosinophils and neutrophils, in vitro.
    MacDonald AJ; Moqbel R; Kay AB
    J Parasitol; 1985 Dec; 71(6):838-40. PubMed ID: 4093819
    [No Abstract]   [Full Text] [Related]  

  • 15. Mouse antibody-dependent eosinophil and macrophage adherence and damage to schistosomula of Schistosoma mansoni.
    Kassis AI; Aikawa M; Mahmoud AF
    J Immunol; 1979 Feb; 122(2):398-405. PubMed ID: 762428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent complement-mediated killing of schistosomula in intraperitoneal diffusion chambers in mice.
    Kassis AI; Warren KS; Mahmoud AA
    J Immunol; 1979 Oct; 123(4):1659-62. PubMed ID: 479595
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotactic factor-induced low density neutrophils express enhanced complement (CR1 and CR3) receptors and increased complement-dependent cytotoxicity.
    Moqbel R; Richerson HB; MacDonald AJ; Walsh GM; Hartnell A; Walport MJ; Kay AB
    Clin Exp Immunol; 1987 Sep; 69(3):676-86. PubMed ID: 2959415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: damage by purieid eosinophils.
    Butterworth AE; David JR; Franks D; Mahmoud AA; David PH; Sturrock RF; Houba V
    J Exp Med; 1977 Jan; 145(1):136-50. PubMed ID: 830787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schistosoma mansoni: complement and antibody damage, mediated by human eosinophils and neutrophils, in killing schistosomula in vitro.
    McKean JR; Anwar AR; Kay AB
    Exp Parasitol; 1981 Jun; 51(3):307-17. PubMed ID: 7227485
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni.
    Khalife J; Dunne DW; Richardson BA; Mazza G; Thorne KJ; Capron A; Butterworth AE
    J Immunol; 1989 Jun; 142(12):4422-7. PubMed ID: 2723436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.